| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | -50 | 62 |
| Effect of foreign exchange rate fluctuations on cash and cash equivalents | 942 | 1,145 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -36,812 | -7,614 |
| Cash and cash equivalents at beginning of period | 168,818 | - |
| Cash and cash equivalents at end of period | 132,006 | - |
STANDARD BIOTOOLS INC. (LAB)
STANDARD BIOTOOLS INC. (LAB)